Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
Thirty-seven patients with nonmetastatic gestational trophoblastic disease (NMGTD) were treated with one or more cycles of oral methotrexate following intramuscular methotrexate as part of induction chemotherapy. Remission was achieved in 31 patients (83.8%). All failures were readily cured with alternate regimens. Prospective studies using this safe, easily administered modality are needed to verify its apparent efficacy.
Barter
J F
JF
Department of Obstetrics and Gynecology, University of Alabama Medical Center, Birmingham 35294.
Soong
S J
SJ
Hatch
K D
KD
Orr
J W
JW
Partridge
E C
EC
Austin
J M
JM
Shingleton
H M
HM
D000284:Administration, Oral; D000328:Adult; D006063:Chorionic Gonadotropin / Q000032:analysis; D018997:Chorionic Gonadotropin, beta Subunit, Human; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010446:Peptide Fragments / Q000032:analysis; D011247:Pregnancy; D012074:Remission Induction; D014328:Trophoblastic Neoplasms / Q000097:blood / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy*
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D003609:Dactinomycin; D008727:Methotrexate